![Thomas Lynch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Lynch
Compliance Officer chez
BILLIONTOONE, INC.
Fortune : 63 469 $ au 31/08/2026
Profil
Thomas P.
Lynch is currently Secretary & Chief Compliance Officer at BillionToOne, Inc. since 2022.
Formerly, served as Secretary, Chief Legal & Compliance Officer at Nuwellis, Inc. from 2018 to 2021; Secretary, Chief Administrative Officer & EVP at Orexigen Therapeutics, Inc. from 2017 to 2018; Senior Legal Counsel at Novartis Corp.
from 2012 to 2015; and Head-Legal & Compliance at Novartis Pharma AG.
Education includes undergraduate studies at Stanford University, graduate degrees from the University of St. Thomas, and Boston College Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/09/2026 | 700 ( 0 % ) | 63 469 $ | 31/08/2026 |
Postes actifs de Thomas Lynch
| Sociétés | Poste | Début |
|---|---|---|
| BILLIONTOONE, INC. | Compliance Officer | - |
Anciens postes connus de Thomas Lynch
| Sociétés | Poste | Fin |
|---|---|---|
| NUWELLIS, INC. | Compliance Officer | 07/06/2021 |
| OREXIGEN THERAPEUTICS, INC. | President | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Conseiller Juridique Général | 01/11/2015 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Compliance Officer | - |
Formation de Thomas Lynch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Nuwellis, Inc.
 Nuwellis, Inc. Medical SpecialtiesHealth Technology Develops heart assist devices | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of St. Thomas
 University of St. Thomas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Boston College Law School
 Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BillionToOne, Inc.
 BillionToOne, Inc. Medical/Nursing ServicesHealth Services Operates as a precision diagnostics company that quantifies biology to create molecular diagnostics | Health Services |
